BACKGROUND & AIMS: Early detection of pancreatic ductal adenocarcinoma (PDAC) allows for surgical resection and increases patient survival times. Imaging agents that bind and amplify the signal of neovascular proteins in neoplasms can be detected by ultrasound, enabling accurate detection of small lesions. We searched for new markers of neovasculature in PDAC and assessed their potential for tumor detection by ultrasound molecular imaging. METHODS: Thymocyte differentiation antigen 1 (Thy1) was identified as a specific biomarker of PDAC neovasculature by proteomic analysis. Up-regulation in PDAC was validated by immunohistochemical analysis of pancreatic tissue samples from 28 healthy individuals, 15 with primary chronic pancreatitis tissues, and 196 with PDAC. Binding of Thy1-targeted contrast microbubbles was assessed in cultured cells, in mice with orthotopic PDAC xenograft tumors expressing human Thy1 on the neovasculature, and on the neovasculature of a genetic mouse model of PDAC. RESULTS: Based on immunohistochemical analyses, levels of Thy1 were significantly higher in the vascular of human PDAC than chronic pancreatitis (P = .007) or normal tissue samples (P < .0001). In mice, ultrasound imaging accurately detected human Thy1-positive PDAC xenografts, as well as PDACs that express endogenous Thy1 in genetic mouse models of PDAC. CONCLUSIONS: We have identified and validated Thy1 as a marker of PDAC that can be detected by ultrasound molecular imaging in mice. The development of a specific imaging agent and identification of Thy1 as a new biomarker could aid in the diagnosis of this cancer and management of patients.
BACKGROUND & AIMS: Early detection of pancreatic ductal adenocarcinoma (PDAC) allows for surgical resection and increases patient survival times. Imaging agents that bind and amplify the signal of neovascular proteins in neoplasms can be detected by ultrasound, enabling accurate detection of small lesions. We searched for new markers of neovasculature in PDAC and assessed their potential for tumor detection by ultrasound molecular imaging. METHODS: Thymocyte differentiation antigen 1 (Thy1) was identified as a specific biomarker of PDAC neovasculature by proteomic analysis. Up-regulation in PDAC was validated by immunohistochemical analysis of pancreatic tissue samples from 28 healthy individuals, 15 with primary chronic pancreatitis tissues, and 196 with PDAC. Binding of Thy1-targeted contrast microbubbles was assessed in cultured cells, in mice with orthotopic PDAC xenograft tumors expressing humanThy1 on the neovasculature, and on the neovasculature of a genetic mouse model of PDAC. RESULTS: Based on immunohistochemical analyses, levels of Thy1 were significantly higher in the vascular of humanPDAC than chronic pancreatitis (P = .007) or normal tissue samples (P < .0001). In mice, ultrasound imaging accurately detected humanThy1-positive PDAC xenografts, as well as PDACs that express endogenous Thy1 in genetic mouse models of PDAC. CONCLUSIONS: We have identified and validated Thy1 as a marker of PDAC that can be detected by ultrasound molecular imaging in mice. The development of a specific imaging agent and identification of Thy1 as a new biomarker could aid in the diagnosis of this cancer and management of patients.
Authors: B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler Journal: Science Date: 2000-08-18 Impact factor: 47.728
Authors: Elizabeth C Verna; Caroline Hwang; Peter D Stevens; Heidrun Rotterdam; Stavros N Stavropoulos; Carolyn D Sy; Martin A Prince; Wendy K Chung; Robert L Fine; John A Chabot; Harold Frucht Journal: Clin Cancer Res Date: 2010-09-28 Impact factor: 12.531
Authors: J L Arbiser; M A Moses; C A Fernandez; N Ghiso; Y Cao; N Klauber; D Frank; M Brownlee; E Flynn; S Parangi; H R Byers; J Folkman Journal: Proc Natl Acad Sci U S A Date: 1997-02-04 Impact factor: 11.205
Authors: Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho Journal: Genes Dev Date: 2003-12-17 Impact factor: 11.361
Authors: Jürgen K Willmann; Zhen Cheng; Corrine Davis; Amelie M Lutz; Meike L Schipper; Carsten H Nielsen; Sanjiv S Gambhir Journal: Radiology Date: 2008-08-11 Impact factor: 11.105
Authors: Abdullah Alajati; Anna M Laib; Holger Weber; Anja M Boos; Arne Bartol; Kristian Ikenberg; Thomas Korff; Hanswalter Zentgraf; Cynthia Obodozie; Ralph Graeser; Sven Christian; Günter Finkenzeller; G Björn Stark; Mélanie Héroult; Hellmut G Augustin Journal: Nat Methods Date: 2008-04-06 Impact factor: 28.547
Authors: Lawrence A Stern; Patrick S Lown; Alexandra C Kobe; Lotfi Abou-Elkacem; Juergen K Willmann; Benjamin J Hackel Journal: ACS Comb Sci Date: 2019-01-24 Impact factor: 3.784
Authors: John J Lee; Rushika M Perera; Huaijun Wang; Dai-Chen Wu; X Shawn Liu; Shiwei Han; Julien Fitamant; Phillip D Jones; Krishna S Ghanta; Sally Kawano; Julia M Nagle; Vikram Deshpande; Yves Boucher; Tomoyo Kato; James K Chen; Jürgen K Willmann; Nabeel Bardeesy; Philip A Beachy Journal: Proc Natl Acad Sci U S A Date: 2014-07-14 Impact factor: 11.205
Authors: Kimberly A Kelly; Michael A Hollingsworth; Randall E Brand; Christina H Liu; Vikesh K Singh; Sudhir Srivastava; Ajay D Wasan; Dhiraj Yadav; Dana K Andersen Journal: Pancreas Date: 2015-11 Impact factor: 3.327
Authors: Hua Zhang; Elizabeth S Ingham; M Karen J Gagnon; Lisa M Mahakian; Jingfei Liu; Josquin L Foiret; Juergen K Willmann; Katherine W Ferrara Journal: Biomaterials Date: 2016-11-21 Impact factor: 12.479